Company attributes
Other attributes
Cellular Biomedicine Group is a biotechnology company developing cell therapies for degenerative and cancerous diseases that is headquartered in Palo Alto California, and was founded in 2009 by Wei William Cao.
The company looks to conduct immuno-ancology as well as stem cell clinical trials in China. They look to utilize products from their laboratory and facilities in China in order to create therapies for treatments of a broad range of cancers. They look to create cancer vaccines, chimeric antigen receptor T-cells, TCR-T, and TIL technologies.
Cellular Biomedicine Group is primarily interested in developing and marketing regeneratice and cell-based therapies that are based on their cellular platforms. They look to cover diseases and issues such as cancer, osteoarthritis, and tissue damages. They offer vertically-integrated CMC for CAR-T Cell Therapy, banking processes for cell preservation and viability, DNA identification for stem cell origin chains, and bio-safety testing. Their facilities meet Chinese CFDA standards.
